These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 17059911

  • 1. Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency.
    Edwards NL.
    Am J Med; 2006 Nov; 119(11 Suppl 1):S29-31. PubMed ID: 17059911
    [No Abstract] [Full Text] [Related]

  • 2. Recognition and management of gout and hyperuricemia.
    Yennie RH.
    JAAPA; 2003 Mar; 16(3):21-4, 27-8, 31. PubMed ID: 14968523
    [No Abstract] [Full Text] [Related]

  • 3. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR, Becker MA, Wortmann RL, Macdonald PA, Hunt B, Streit J, Lademacher C, Joseph-Ridge N.
    Arthritis Rheum; 2008 Nov 15; 59(11):1540-8. PubMed ID: 18975369
    [Abstract] [Full Text] [Related]

  • 4. Hyperuricaemia and gout.
    Shipley M.
    J R Coll Physicians Edinb; 2011 Sep 15; 41(3):229-33. PubMed ID: 21949921
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine-induced hyperuricemia and gout in renal transplants.
    Ben Hmida M, Hachicha J, Bahloul Z, Kaddour N, Kharrat M, Jarraya F, Jarraya A.
    Transplant Proc; 1995 Oct 15; 27(5):2722-4. PubMed ID: 7482890
    [No Abstract] [Full Text] [Related]

  • 6. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
    Chohan S, Becker MA, MacDonald PA, Chefo S, Jackson RL.
    Arthritis Care Res (Hoboken); 2012 Feb 15; 64(2):256-61. PubMed ID: 22052584
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S.
    Nihon Rinsho; 2008 Apr 15; 66(4):729-35. PubMed ID: 18409523
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Urate-lowering therapy for gout: focus on febuxostat.
    Love BL, Barrons R, Veverka A, Snider KM.
    Pharmacotherapy; 2010 Jun 15; 30(6):594-608. PubMed ID: 20500048
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.